|
1
|
Xu S, Tang L, Li X, Fan F and Liu Z:
Immunotherapy for glioma: Current management and future
application: Cancer. Lett. 476:1–12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo
Y, Ren D, Hua Y, Yu B, Zhou Y, et al: Mechanisms of vasculogenic
mimicry in hypoxic tumor microenvironments. Mol Cancer.
20(7)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lim D, Do Y, Kwon BS, Chang W, Lee MS, Kim
J and Cho JG: Angiogenesis and vasculogenic mimicry as therapeutic
targets in ovarian cancer. BMB Rep. 53:291–298. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li H, Wang D, Yi B, Cai H, Wang Y, Lou X,
Xi Z and Li Z: SUMOylation of IGF2BP2 promotes vasculogenic mimicry
of glioma via regulating OIP5-AS1/miR-495-3p axis. Int J Biol Sci.
17:2912–2930. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Morales-Guadarrama G, García-Becerra R,
Méndez-Pérez EA, García-Quiroz J, Avila E and Díaz L: Vasculogenic
mimicry in breast cancer: Clinical relevance and drivers. Cells.
10(1758)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Luo Y, Yang Z, Yu Y and Zhang P: HIF1α
lactylation enhances KIAA1199 transcription to promote angiogenesis
and vasculogenic mimicry in prostate cancer. Int J Biol Macromol.
222:2225–2243. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu Y, Li F, Yang YT, Xu XD, Chen JS, Chen
TL, Chen HJ, Zhu YB, Lin JY, Li Y, et al: IGFBP2 promotes
vasculogenic mimicry formation via regulating CD144 and MMP2
expression in glioma. Oncogene. 38:1815–1831. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cai HP, Wang J, Xi SY, Ni XR, Chen YS, Yu
YJ, Cen ZW, Yu ZH, Chen FR, Guo CC, et al: Tenascin-cmediated
vasculogenic mimicry formation via regulation of MMP2/MMP9 in
glioma. Cell Death Dis. 10(879)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li Y, Liu Z and Zhang Y: Expression and
prognostic impact of FZDs in pancreatic adenocarcinoma. BMC
Gastroenterol. 21(79)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ou H, Chen Z, Xiang L, Fang Y, Xu Y, Liu
Q, Hu Z, Li X, Huang Y and Yang D: Frizzled 2-induced
epithelial-mesenchymal transition correlates with vasculogenic
mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
Cancer Sci. 110:1169–1182. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Huang L, Luo EL, Xie J, Gan RH, Ding LC,
Su BH, Zhao Y, Lin LS, Zheng DL and Lu YG: FZD2 regulates cell
proliferation and invasion in tongue squamous cell carcinoma. Int J
Biol Sci. 15:2330–2339. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yin P, Wang W, Gao J, Bai Y, Wang Z, Na L,
Sun Y and Zhao C: Fzd2 Contributes to breast cancer cell
mesenchymal-like stemness and drug resistance. Oncol Res.
28:273–284. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ding LC, Huang XY, Zheng FF, Xie J, She L,
Feng Y, Su BH, Zheng DL and Lu YG: FZD2 inhibits the cell growth
and migration of salivary adenoid cystic carcinomas. Oncol Rep.
35:1006–1012. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Huang K, Xu H, Han L, Xu R, Xu Z and Xie
Y: Identification of therapeutic targets and prognostic biomarkers
among frizzled family genes in glioma. Front Mol Biosci.
9(1054614)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li C, Tang Z, Zhang W, Ye Z and Liu F:
GEPIA2021: Integrating multiple deconvolution-based analysis into
GEPIA. Nucleic Acids Res. 49:W242–W246. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chandrashekar DS, Karthikeyan SK, Korla
PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne
U, et al: UALCAN: An update to the integrated cancer data analysis
platform. Neoplasia. 25:18–27. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao Z, Zhang KN, Wang Q, Li G, Zeng F,
Zhang Y, Wu F, Chai R, Wang Z, Zhang C, et al: Chinese glioma
genome atlas (CGGA): A comprehensive resource with functional
genomic data from Chinese glioma patients. Genomics Proteomics
Bioinformatics. 19:1–12. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tuluhong D, Chen T, Wang J, Zeng H, Li H,
Dunzhu W, Li Q and Wang S: FZD2 promotes TGF-β-induced
epithelial-to-mesenchymal transition in breast cancer via
activating notch signaling pathway. Cancer Cell Int.
21(199)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li Q, Wang J, Ma X, Wang M and Zhou L:
POFUT1 acts as a tumor promoter in glioblastoma by enhancing the
activation of notch signaling. J Bioenerg Biomembr. 53:621–632.
2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu S, Ruan X, Liu X, Zhang F, Wang D, Liu
Y, Yang C, Shao L, Liu Q, Zhu L, et al: HNRNPD interacts with ZHX2
regulating the vasculogenic mimicry formation of glioma cells via
linc00707/miR-651-3p/SP2 axis. Cell Death Dis.
12(153)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vredenburgh JJ, Desjardins A, Herndon JE
II, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S,
Gururangan S, Wagner M, et al: Phase II trial of bevacizumab and
irinotecan in recurrent malignant glioma. Clin Cancer Res.
13:1253–1259. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhu Y, Liu X, Zhao P, Zhao H, Gao W and
Wang L: Celastrol suppresses glioma vasculogenic mimicry formation
and angiogenesis by blocking the PI3K/Akt/mTOR signaling pathway.
Front Pharmacol. 11(25)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pan Z, Zhu Q, You W, Shen C, Hu W and Chen
X: Silencing of Mig-7 expression inhibits in-vitro invasiveness and
vasculogenic mimicry of human glioma U87 cells. Neuroreport.
30:1135–1142. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Medina MA, Muñoz-Chápuli R and Quesada AR:
Challenges of antiangiogenic cancer therapy: Trials and errors, and
renewed hope. J Cell Mol Med. 11:374–382. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hori K, Sen A and Artavanis-Tsakonas S:
Notch signaling at a glance. J Cell Sci. 126:2135–2140.
2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Siebel C and Lendahl U: Notch signaling in
development, tissue homeostasis, and disease. Physiol Rev.
97:1235–1294. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hai L, Zhang C, Li T, Zhou X, Liu B, Li S,
Zhu M, Lin Y, Yu S, Zhang K, et al: Notch1 is a prognostic factor
that is distinctly activated in the classical and proneural subtype
of glioblastoma and that promotes glioma cell survival via the
NF-κB(p65) pathway. Cell Death Dis. 9(158)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating β-catenin and NF-κB signaling
via AKT activation. Cancer Sci. 103:181–190. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yi L, Zhou X, Li T, Liu P, Hai L, Tong L,
Ma H, Tao Z, Xie Y, Zhang C, et al: Notch1 signaling pathway
promotes invasion, self-renewal and growth of glioma initiating
cells via modulating chemokine system CXCL12/CXCR4. J Exp Clin
Cancer Res. 38(339)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu H, Zhang Y, Qi L, Ding L, Jiang H and
Yu H: NFIX circular RNA promotes glioma progression by regulating
miR-34a-5p via notch signaling pathway. Front Mol Neurosci.
11(225)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Parmigiani E, Taylor V and Giachino C:
Oncogenic and tumor-suppressive functions of NOTCH signaling in
glioma. Cells. 9(2304)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gao J, Fan L, Zhao L and Su Y: The
interaction of notch and Wnt signaling pathways in vertebrate
regeneration. Cell Regen. 10(11)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Borggrefe T, Lauth M, Zwijsen A,
Huylebroeck D, Oswald F and Giaimo BD: The Notch intracellular
domain integrates signals from Wnt, hedgehog, TGFβ/BMP and hypoxia
pathways. Biochim Biophys Acta. 1863:303–313. 2016.PubMed/NCBI View Article : Google Scholar
|
